[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356471-105":59,"doc-detail-356471-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","association-of-germline-variants-with-kras-mutation-status-in-colorectal-cancer","Association of germline variants with KRAS-mutation status in colorectal cancer","","Somatic mutations in KRAS drive colorectal cancer (CRC) and vary across race, sex, tumor site, ethnicity, and genetic similarity. This study evaluates whether inherited germline variants influence KRAS somatic mutation frequency by affecting mutation, DNA repair, and downstream cellular or microenvironmental responses. A genome-wide association study in 7071 CRC individuals used KRAS mutation status as the phenotype, selecting validated SNVs via discovery GWAS P values, in silico functional predictions, and gene proximity. Validation of 101 SNVs in 2482 individuals found no significant associations with KRAS-mutant CRC, and rs73067863-T showed only a non-significant exploratory effect.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/association-of-germline-variants-with-kras-mutation-status-in-colorectal-cancer/356471/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/association-of-germline-variants-with-kras-mutation-status-in-colorectal-cancer/356471.png","ImageObject",300,407,{"name":92,"@type":93},"Genevieve","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does this study address about KRAS and colorectal cancer?","Question",{"text":112,"@type":113},"It tests whether inherited germline genetic background modifies the frequency of KRAS somatic mutations in colorectal cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the discovery phase performed?",{"text":117,"@type":113},"A genome-wide association study (GWAS) was conducted in 7071 colorectal cancer individuals using KRAS mutation status as the phenotype.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main findings from the validation phase?",{"text":121,"@type":113},"Validation of 101 candidate SNVs in 2482 individuals found no SNVs significantly associated with KRAS-mutant CRC; rs73067863-T showed only a non-significant exploratory association.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356471,1790194343,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974585,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nAssociation of germline variants with KRAS-mutation status in colorectal cancer  \nNijole Pollock Tjader1,2, Johnny Ramroop3, Tanish Gandhi4, Cara Dauch1, Owen Meadows1,5, Patrick Stevens2, Rachel Pearlman6, Heather Hampel7, Elom K. Aglago8, Sonja I. Berndt9, Amanda Bloomer10, Hermann Brenner11,12,13, Daniel D. Buchanan14,15, Peter T. Campbell16,  \nYin Cao17,18,19, Andrew T. Chan20,21,22, Iona Cheng23, Niki Dimou24, DavidA. Drew21,22, Amy J. French25, Peter Georgeson14, Marios Giannakis26,27,28, Graham G. Giles29,30,31, Maria Gomez10,32, Stephen B. Gruber33, Michael Hoffmeister11, Wen-Yi Huang9, Meredith A. J. Hullar34, Jeroen R. Huyghe34, Nicole Loroña35, Victor Moreno36,37,38,39, Christina C. Newton40, Jonathan A. Nowak41, Mireia Obón-Santacana36,37,38,  \nShuji Ogino27,41,42, Andrew Pellatt43, Anita R. Peoples40, Jennifer B. Permuth10,32, Stephanie L. Schmit44,45, Robert E. Schoen46, Erin M. Siegel10, Robert S. Steinfelder34, Wei Sun34, Jamie K. Teer47, Claire E. Thomas34, Quang M. Trinh48, KonstantinosTsilidis8,49, Tomotaka Ugai41,42,50, Caroline Y. Um40, Bethany Van Guelpen51,52, Syed H. Zaidi48, Jane Figueiredo53,54, Ulrike Peters34, Amanda I. Phipps34,55, Joseph Paul McElroy56 & Amanda Ewart Toland1,6􀀍  \nSomatic mutations in KRAS are a common driver of colorectal cancer (CRC) and present at different frequencies by race, sex, tumor site, ethnicity, and genetic similarity. Inherited germline variants may influence tumor somatic mutation frequency by altering mutation or DNA repair processes or altering cellular, immunological and/or microenvironmental responses after a mutation. We hypothesized that the germline genetic background modifies somatic KRAS mutation frequency inCRC. To test this, we performed a genome-wide association study (GWAS) in 7071 individuals with CRC, using KRAS mutation status as the phenotype. Single-nucleotide variants were chosen for validation analyses based on P values from the discovery GWAS, predicted in silico functional effects, and proximity to genes with potential cancer relevance. A validation analysis of 101 SNVs of interest was performed in 2482 individuals. No SNVs were significantly associated with KRAS-mutant CRC (P value \u003C 0.0005) . One variant rs73067863-T showed a non-significant exploratory association with fewer KRAS-mutant tumors in the combined sample (P value = 9.7 × 10–7, OR = 0.75) . Follow-up studies are needed to determine if these or other germline variants impact population differences in KRAS mutations in CRC.  \nKeywords Colorectal cancer, KRAS, GWAS, Somatic mutations, Germline variants  \n1Department of Cancer Biology and Genetics, Comprehensive Cancer Center, College of Medicine, The Ohio State University Wexner Medical Center, 460 West 12th Avenue, Biomedical Research Tower Room 998, Columbus, OH 43210, USA. 2Department of Biomedical Informatics, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA. 3Biology Department, The City College of New York, The City University of New York, New York, NY, USA. 4College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA. 5Department of Pathology, Case Western Reserve University, Cleveland, OH, USA. 6Division of Human Genetics, Department of Internal Medicine, Comprehensive Cancer Center, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA. 7Division of Clinical Cancer Genomics, City of Hope National Medical Center, Duarte, CA, USA. 8Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. 9Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. 10Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA. 11Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. 12C","cbCaim1RqbAVSKjh","https://ap.wps.com/l/cbCaim1RqbAVSKjh","pdf",3575725,13,"English","# Background\n# Study design and validation strategy\n# Results\n# Implications and future directions","[{\"question\":\"What question does this study address about KRAS and colorectal cancer?\",\"answer\":\"It tests whether inherited germline genetic background modifies the frequency of KRAS somatic mutations in colorectal cancer.\"},{\"question\":\"How was the discovery phase performed?\",\"answer\":\"A genome-wide association study (GWAS) was conducted in 7071 colorectal cancer individuals using KRAS mutation status as the phenotype.\"},{\"question\":\"What were the main findings from the validation phase?\",\"answer\":\"Validation of 101 candidate SNVs in 2482 individuals found no SNVs significantly associated with KRAS-mutant CRC; rs73067863-T showed only a non-significant exploratory association.\"}]","Association of germline variants with KRAS-mutation status in colorectal cancer | PDF",1790125469,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ac80cf6cb804c1da7f6bf8bb8a972ca.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e49944c011a65ccb1b492ca56c7f3f9.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d809e0260297fe74cac74503c3b96ce7.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/699c0d4b541a486fab804c3fdbdac6f8.webp",980,1287]